EMEA-002147-PIP02-17

Key facts

Active substance
Sodium thiosulfate
Therapeutic area
Oncology
Decision number
P/0312/2018
PIP number
EMEA-002147-PIP02-17
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Prevention of platinum-induced ototoxic hearing loss
Route(s) of administration
Intravenous use
Contact for public enquiries
Fennec Pharmaceuticals, Inc.

E-mail: info@s-cubed.co.uk
Tel. +44 1235772260

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating